Introduction
Giusep S1500/100 and Criticef S1500 are Astemax Biotech’s branded injections combining Ceftriaxone (typically 1000-1500 mg) with Sulbactam Sodium (100-500 mg), offering broad-spectrum coverage against resistant bacterial infections.
Key Ingredients
Ceftriaxone, a third-generation cephalosporin, disrupts bacterial cell wall synthesis to kill Gram-positive and Gram-negative pathogens. Sulbactam enhances efficacy by inhibiting beta-lactamase enzymes, protecting ceftriaxone from degradation in resistant strains.
Health Benefits
These formulations treat severe conditions like pneumonia, sepsis, meningitis, intra-abdominal infections (e.g., peritonitis), skin/soft tissue infections, complicated UTIs, and surgical prophylaxis, reducing mortality in hospitalized patients. The combination achieves higher success rates (80-90%) against beta-lactamase producers compared to ceftriaxone
